Page 8 - Value Based Purchasing Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and analyses; and other health policy news. Week in Review Highlight of the Week: This week, CMS issued its proposed FY 2022 payment updates for inpatient psychiatric and rehabilitation facilities, hospice, and skilled nursing facilities. Read more about the updates and other news below. I. Regulations, Notices & Guidance On April 5, 2021, the Food and Drug Administration (FDA) issued guidance entitled, Development of Abbreviated New Drug Applications During the COVID-19 Pandemic Questions and Answers Guidance for Industry. FDA is issuing this guidance to provide general recommendations to prospective applicants and applicants of abbreviated new drug applications (ANDAs) related to generic drug product development and regulatory submissions in the form of

Communications commissionHealth resourcesCelltrans incDevelopment of abbreviated new drug applications duringVaccine programOther health policy newsMeeting of the national vaccine advisory committeeDepartment of healthExpenditure panel surveyBiden administration special enrollment periodCongressional budget officeGene therapies advisory committeeHome health quality reporting program requirementsCenters for diseaseCenters for medicare medicaid servicesResearch initiatives workshop